I would be quite surprised if they waited a year to do the R/S. We've got to get off this exchange and doing a R/S is intended to do just that. I just don't see us floundering on this exchange for another year. But if they do and we stay at these low prices. Then I will definitely take full advantage. Also, regardless of the R/S, as we meet milestones, get to design freeze and get closer to FDA submission. The PPS should organically appreciate. How much? Who knows. It's anyone's guess.
News 
Market Data 
Discover 
AI
